Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Cell damage by excess CuZnSOD and Down's syndrome.

Groner Y, Elroy-Stein O, Avraham KB, Schickler M, Knobler H, Minc-Golomb D, Bar-Peled O, Yarom R, Rotshenker S.

Biomed Pharmacother. 1994;48(5-6):231-40.

PMID:
7999984
3.

[Transgenic mice overexpressing copper-zinc superoxide dismutase: a model for the study of radical mechanisms and aging].

Ceballos-Picot I.

C R Seances Soc Biol Fil. 1993;187(3):308-23. Review. French.

PMID:
8019910
5.

Understanding mental retardation in Down's syndrome using trisomy 16 mouse models.

Galdzicki Z, Siarey RJ.

Genes Brain Behav. 2003 Jun;2(3):167-78. Review.

6.
7.

The role of alterations in free radical metabolism in mediating cognitive impairments in Down's syndrome.

Brugge KL, Nichols S, Delis D, Saitoh T, Truaner D.

EXS. 1992;62:190-8. Review.

PMID:
1450586
8.

Structural variation of chromosome 21 and symptoms of Down's syndrome.

Rethoré MO.

Hum Genet Suppl. 1981;2:173-82. Review.

PMID:
6218134
9.

Neuronal cell death in Down's syndrome.

Sawa A.

J Neural Transm Suppl. 1999;57:87-97. Review.

PMID:
10666670
10.

Developmental instability of the cerebellum and its relevance to Down syndrome.

Shapiro BL.

J Neural Transm Suppl. 2001;(61):11-34. Review.

PMID:
11771737
11.

The cholinergic system in Down's syndrome.

Fodale V, Mafrica F, Caminiti V, Grasso G.

J Intellect Disabil. 2006 Sep;10(3):261-74. Review.

PMID:
16916850
12.

Hematological changes in Down's syndrome.

Ganick DJ.

Crit Rev Oncol Hematol. 1986;6(1):55-69. Review.

PMID:
2946491
13.

Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.

Stalmans I.

Verh K Acad Geneeskd Belg. 2005;67(4):229-76. Review.

PMID:
16334858
14.

Mitochondrial dysfunction and Down's syndrome.

Arbuzova S, Hutchin T, Cuckle H.

Bioessays. 2002 Aug;24(8):681-4. Review.

PMID:
12210526
15.

Human neural stem cells: a new tool for studying cortical development in Down's syndrome.

Bhattacharyya A, Svendsen CN.

Genes Brain Behav. 2003 Jun;2(3):179-86. Review.

16.

Ets transcription factors and targets in osteogenesis.

Raouf A, Seth A.

Oncogene. 2000 Dec 18;19(55):6455-63. Review.

17.

Protein expression in Down syndrome brain.

Engidawork E, Lubec G.

Amino Acids. 2001 Dec;21(4):331-61. Review.

PMID:
11858695
18.

Molecular neuropathology of transgenic mouse models of Down syndrome.

Cairns NJ.

J Neural Transm Suppl. 2001;(61):289-301. Review.

PMID:
11771752
19.

The neuropathology of the trisomy 16 mouse.

Lacey-Casem ML, Oster-Granite ML.

Crit Rev Neurobiol. 1994;8(4):293-322. Review.

PMID:
7850875
20.

Functional implications of gene dosage effects in trisomy 21.

Epstein CJ, Epstein LB, Cox DR, Weil J.

Hum Genet Suppl. 1981;2:155-72. Review. No abstract available.

PMID:
6185454

Supplemental Content

Support Center